Tuberc Respir Dis Search



  • HOME
  • Search
Erlotinib Induced Trichomegaly of the Eyelashes
Sang-Hoon Jeon, Jeong-Seon Ryu, Gwang-Seong Choi, Jung-Soo Kim, Hea-Yoon Kwon, Min-Su Kim, Hae-Seong Nam, Jae-Hwa Cho, Seung-Min Kwak, Hong Lyeol Lee, Hyun-Jung Kim, Geun-Jeong Hong
Tuberc Respir Dis. 2013;74(1):37-40.   Published online January 31, 2013
Full text    PubReader    Crossref - TDM    PDF    
Successful Rechallenge with Gefitinib for an Initial Erlotinib-Responder with Advanced Lung Adenocarcinoma.
Sung Chul Hong, Yun Su Sim, Jin Hwa Lee, Yon Ju Ryu, Jung Hyun Chang
Tuberc Respir Dis. 2011;71(4):286-290.   Published online October 1, 2011
Comparison of Therapeutic Efficacy of Gefitinib and Erlotinib in Patients with Squamous Cell Lung Cancer.
Hong Joon Shin, Tae Ok Kim, Hyun Wook Kang, Su Young Chi, Hee Jung Ban, Soo Ok Kim, Yong Soo Kwon, In Jae Oh, Kyu Sik Kim, Yu Il Kim, Sung Chul Lim, Young Chul Kim
Tuberc Respir Dis. 2011;71(1):15-23.   Published online July 1, 2011
Erlotinib-Related Spontaneous Pneumothorax in Patient with Primary Lung Cancer.
Hae Seong Nam, Hyeon Jeong Lee, Min Su Kim, Sung Wook Park, Sang Hoon Jeon, Jae Hwa Cho, Seung Min Kwak, Hong Lyeol Lee, Jeong Seon Ryu
Tuberc Respir Dis. 2010;69(6):465-468.   Published online December 1, 2010
Recurrent Erlotinib-Induced Interstitial Lung Disease on Non-Small Cell Lung Cancer.
Sang Don Park, Areum Kim, Jin Seok Park, Chun Ho Shin, Hae Sung Nam, Lucia Kim, Jae Wha Cho, Jeong Sun Ryu, Seung Min Kwak
Tuberc Respir Dis. 2009;67(5):445-448.   Published online November 1, 2009
  • SCImago Journal & Country Rank

Article category

Browse all articles >


Browse all articles >

Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail:                

Copyright © 2020 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2community

Close layer
prev next